BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25846193)

  • 1. Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1.
    Liu K; Zhang C; Li T; Ding Y; Tu T; Zhou F; Qi W; Chen H; Sun X
    Int J Oncol; 2015; 46(6):2526-34. PubMed ID: 25846193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor let-7a inhibits breast cancer cell proliferation, migration and invasion by targeting MAGE-A1.
    Mi Y; Liu F; Liang X; Liu S; Huang X; Sang M; Geng C
    Neoplasma; 2019 Jan; 66(1):54-62. PubMed ID: 30509089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-21: A gene of dual regulation in breast cancer.
    Zhang C; Liu K; Li T; Fang J; Ding Y; Sun L; Tu T; Jiang X; Du S; Hu J; Zhu W; Chen H; Sun X
    Int J Oncol; 2016 Jan; 48(1):161-72. PubMed ID: 26549725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. let-7i inhibits proliferation and migration of bladder cancer cells by targeting HMGA1.
    Qin MM; Chai X; Huang HB; Feng G; Li XN; Zhang J; Zheng R; Liu XC; Pu C
    BMC Urol; 2019 Jun; 19(1):53. PubMed ID: 31196036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Let-7a mimic attenuates CCL18 induced breast cancer cell metastasis through Lin 28 pathway.
    Wang L; Wang YX; Zhang DZ; Fang XJ; Sun PS; Xue HC
    Biomed Pharmacother; 2016 Mar; 78():301-307. PubMed ID: 26898455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGA1-Regulating microRNAs Let-7a and miR-26a are Downregulated in Human Seminomas.
    De Martino M; Esposito F; Pellecchia S; Cortez Cardoso Penha R; Botti G; Fusco A; Chieffi P
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7.
    Kim SJ; Shin JY; Lee KD; Bae YK; Sung KW; Nam SJ; Chun KH
    Breast Cancer Res; 2012 Jan; 14(1):R14. PubMed ID: 22251626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor decreases CMYC and KRAS expression by upregulating let-7a expression in ER-, PR-, AR+ breast cancer.
    Lyu S; Yu Q; Ying G; Wang S; Wang Y; Zhang J; Niu Y
    Int J Oncol; 2014 Jan; 44(1):229-37. PubMed ID: 24172884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer.
    Zhao XX; Yuan QZ; Mu DP; Sun DW; Bo QA; Pan GZ; Li GQ; Cui T; Ding PP; You FP; Hao L; Wang MX; Zhang J
    Int J Clin Exp Pathol; 2015; 8(1):368-73. PubMed ID: 25755724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.
    Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
    Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide inhibits cell growth and motility via up-regulation of let-7a in breast cancer cells.
    Shi Y; Cao T; Huang H; Lian C; Yang Y; Wang Z; Ma J; Xia J
    Cell Cycle; 2017; 16(24):2396-2403. PubMed ID: 28980872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA.
    Serguienko A; Grad I; Wennerstrøm AB; Meza-Zepeda LA; Thiede B; Stratford EW; Myklebost O; Munthe E
    Oncotarget; 2015 Feb; 6(4):2451-65. PubMed ID: 25669981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.
    Iwasaki T; Tanaka K; Kawano M; Itonaga I; Tsumura H
    Int J Oncol; 2015 Apr; 46(4):1543-50. PubMed ID: 25647078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Let-7 Status Is Crucial for PARP1 Expression in HER2-Overexpressing Breast Tumors.
    Wielgos ME; Rajbhandari R; Cooper TS; Wei S; Nozell S; Yang ES
    Mol Cancer Res; 2017 Mar; 15(3):340-347. PubMed ID: 28031413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA
    Wu Z; Wang W; Wang Y; Wang X; Sun S; Yao Y; Zhang Y; Ren Z
    Cell Cycle; 2020 Mar; 19(5):610-624. PubMed ID: 32052688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-trans-retinoic acid modulates glycolysis via H19 and telomerase: the role of mir-let-7a in estrogen receptor-positive breast cancer cells.
    El Habre R; Aoun R; Tahtouh R; Hilal G
    BMC Cancer; 2024 May; 24(1):615. PubMed ID: 38773429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Let-7a inhibits tumor cell growth and metastasis by directly targeting RTKN in human colon cancer.
    Li B; Chen P; Chang Y; Qi J; Fu H; Guo H
    Biochem Biophys Res Commun; 2016 Sep; 478(2):739-45. PubMed ID: 27498032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiRNA-10b sponge: An anti-breast cancer study in vitro.
    Liang AL; Zhang TT; Zhou N; Wu CY; Lin MH; Liu YJ
    Oncol Rep; 2016 Apr; 35(4):1950-8. PubMed ID: 26820121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.
    Zhang J; Kong X; Li J; Luo Q; Li X; Shen L; Chen L; Fang L
    Oncol Rep; 2014 Mar; 31(3):1357-63. PubMed ID: 24366472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
    Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
    Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.